These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25135328)

  • 1. Rosuvastatin treatment improves arterial stiffness with lowering blood pressure in healthy hypercholesterolemic patients.
    Oh PC; Han SH; Koh KK; Lee K; Seo JG; Suh SY; Ahn T; Choi IS; Shin EK
    Int J Cardiol; 2014 Oct; 176(3):1284-7. PubMed ID: 25135328
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia.
    Pirro M; Schillaci G; Mannarino MR; Savarese G; Vaudo G; Siepi D; Paltriccia R; Mannarino E
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):436-41. PubMed ID: 17134956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia.
    Ott C; Ritt M; Titze SI; Schäufele T; Schmieder RE
    J Nephrol; 2009; 22(5):675-81. PubMed ID: 19810001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia.
    Ott C; Schlaich MP; Schmidt BM; Titze SI; Schäufele T; Schmieder RE
    Atherosclerosis; 2008 Feb; 196(2):704-11. PubMed ID: 17298834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological and clinical profile of rosuvastatin calcium (Crestor)].
    Ohfuji K; Yano S; Yamaguchi M; Smith G; Hirata M; Shimada H; Izuishi K; Shinagawa J; Matsunaga K
    Nihon Yakurigaku Zasshi; 2005 Sep; 126(3):213-9. PubMed ID: 16272766
    [No Abstract]   [Full Text] [Related]  

  • 6. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
    Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid lowering by rosuvastatin: how do statins differ?].
    Laufs U
    Dtsch Med Wochenschr; 2015 Mar; 140(5):313. PubMed ID: 25734669
    [No Abstract]   [Full Text] [Related]  

  • 8. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin improves pulse wave reflection by restoring endothelial function.
    Ott C; Schneider MP; Schlaich MP; Schmieder RE
    Microvasc Res; 2012 Jul; 84(1):60-4. PubMed ID: 22484031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure.
    Chello M; Spadaccio C
    Cardiology; 2013; 124(1):36-7. PubMed ID: 23295545
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosuvastatin calcium.
    Quirk J; Thornton M; Kirkpatrick P
    Nat Rev Drug Discov; 2003 Oct; 2(10):769-70. PubMed ID: 14579811
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
    Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
    Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin, the black box.
    Hatem S; Boccara F
    Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
    [No Abstract]   [Full Text] [Related]  

  • 15. [New statin introduction. With more power against hypercholesterolemia].
    MMW Fortschr Med; 2002 Dec; 144(50):64. PubMed ID: 14610873
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimizing the pharmacology of statins: characteristics of rosuvastatin.
    Chapman MJ; McTaggart F
    Atheroscler Suppl; 2002 Apr; 2(4):33-6; discussion 36-7. PubMed ID: 11976075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.
    Tomizawa A; Hattori Y; Suzuki K; Okayasu T; Kase H; Satoh H; Kasai K
    Int J Cardiol; 2010 Sep; 144(1):108-9. PubMed ID: 19174316
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.
    Kang BY; Wang W; Palade P; Sharma SG; Mehta JL
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):327-34. PubMed ID: 19687748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of rosuvastatin in current lipid-lowering therapy].
    Abel T; Fehér J
    Orv Hetil; 2010 Aug; 151(35):1424-8. PubMed ID: 20719717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits.
    Ozaki MR; de Almeida EA
    Exp Toxicol Pathol; 2013 Mar; 65(3):297-304. PubMed ID: 22024507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.